Table 2.

Association of IL-10/-592 and IL10RB/c238 genotypes with grades III-IV acute GVHD


Genotype (number)

Incidence of GVHD, %

Hazard ratio

Trend P*
Patient genotype    
   IL-10/-592     <.001  
      C/C (504)   22   Reference   
      A/C (368)   16   0.7 (0.5-0.9)   
      A/A (81)   10   0.4 (0.2-0.8)   
   IL10RB/c238     .31  
      A/A (494)   21   Reference   
      A/G (385)   16   0.8 (0.6-1.0)   
      G/G (74)   20   1.0 (0.6-1.7)   
Donor genotype    
   IL-10/-592     .03  
      C/C (492)   21   Reference   
      A/C (371)   17   0.8 (0.6-1.1)   
      A/A (90)   13   0.6 (0.3-1.0)   
   IL10RB/c238     .02  
      A/A (515)   21   Reference   
      A/G (356)   17   0.8 (0.5-1.0)   
      G/G (82)
 
12
 
0.6 (0.3-1.1)
 

 

Genotype (number)

Incidence of GVHD, %

Hazard ratio

Trend P*
Patient genotype    
   IL-10/-592     <.001  
      C/C (504)   22   Reference   
      A/C (368)   16   0.7 (0.5-0.9)   
      A/A (81)   10   0.4 (0.2-0.8)   
   IL10RB/c238     .31  
      A/A (494)   21   Reference   
      A/G (385)   16   0.8 (0.6-1.0)   
      G/G (74)   20   1.0 (0.6-1.7)   
Donor genotype    
   IL-10/-592     .03  
      C/C (492)   21   Reference   
      A/C (371)   17   0.8 (0.6-1.1)   
      A/A (90)   13   0.6 (0.3-1.0)   
   IL10RB/c238     .02  
      A/A (515)   21   Reference   
      A/G (356)   17   0.8 (0.5-1.0)   
      G/G (82)
 
12
 
0.6 (0.3-1.1)
 

 
*

Multivariable proportional hazard regression analysis adjusted for age at transplantation, transplantation year, sex mismatch, use of total body irradiation in the conditioning regimen, and disease risk group

or Create an Account

Close Modal
Close Modal